Director Michael Weiser granted 90,316 deferred RSUs at IOVANCE (NASDAQ: IOVA)
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
WEISER MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
IOVANCE BIOTHERAPEUTICS director Michael Weiser received a grant of 90,316 deferred restricted stock units on June 16, 2026. Each unit represents one share of common stock under the 2018 Equity Incentive Plan. The units vest on the earlier of one year after the grant date or just before the next annual shareholder meeting, and delivery of shares is deferred until specific future events. Following this grant, Weiser holds 90,316 deferred restricted stock units directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
WEISER MICHAEL
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Restricted Stock Unit | 90,316 | $0.00 | -- |
Holdings After Transaction:
Deferred Restricted Stock Unit — 90,316 shares (Direct, null)
Footnotes (1)
- Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.
Key Figures
Deferred RSU grant: 90,316 units
Grant price: $0.00 per unit
Post-grant holdings: 90,316 units
+1 more
4 metrics
Deferred RSU grant
90,316 units
Granted on June 16, 2026 to director Michael Weiser
Grant price
$0.00 per unit
Deferred restricted stock unit award under 2018 Equity Incentive Plan
Post-grant holdings
90,316 units
Deferred restricted stock units following this transaction
Outer issuance limit
10 years
Latest date for share issuance from grant date
Key Terms
Deferred Restricted Stock Unit, 2018 Equity Incentive Plan, vest, change in control
4 terms
Deferred Restricted Stock Unit financial
"Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share"
2018 Equity Incentive Plan financial
"are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended)"
vest financial
"the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
change in control financial
"a change in control (as defined in the DRSU agreement)"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
FAQ
What insider transaction did IOVANCE BIOTHERAPEUTICS (IOVA) report for Michael Weiser?
IOVANCE BIOTHERAPEUTICS reported that director Michael Weiser received 90,316 deferred restricted stock units on June 16, 2026. These units are a stock-based compensation award, not an open-market purchase or sale, and are tied to future service-based vesting conditions.
How many IOVA deferred restricted stock units did Michael Weiser acquire in this Form 4?
Michael Weiser acquired 90,316 deferred restricted stock units in this transaction. Each unit is linked to one share of IOVANCE BIOTHERAPEUTICS common stock and was granted at a price of $0.00 under the company’s 2018 Equity Incentive Plan.
When do Michael Weiser’s IOVA deferred restricted stock units vest?
The deferred restricted stock units vest on the earlier of the first anniversary of the June 16, 2026 grant date or the day before IOVANCE BIOTHERAPEUTICS’ next annual shareholder meeting, provided Michael Weiser continues serving the company through that vesting date.
Are Michael Weiser’s IOVA deferred restricted stock units held directly or indirectly?
The Form 4 shows Michael Weiser’s 90,316 deferred restricted stock units as a direct holding. The ownership code is listed as “D,” indicating direct ownership rather than indirect ownership through an entity or trust structure.